Companies: 10,795·Total market cap: $144.5T
Immuneering Corporation

Immuneering Corporation

IMRXNASDAQHealthcare● Active
$3.93
$-0.34(-7.96%)
Market Cap$142668188
P/E Ratio
52W High$10.08
52W Low$1.66
Overview

Immuneering Corporation (IMRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · IMRX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.17imrx eps ttm · imrx earnings per shareEarnings history
PE Ratio (TTM)imrx pe ratio ttm · imrx price to earningsPE Ratio deep dive
Revenue (TTM)0.00imrx revenue ttm · imrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes imrx pay dividends · imrx dividend yieldDividend history
Shares Outstanding44.0Mimrx shares outstanding · imrx floatShares outstanding history
Next EarningsAug 12, 2026Est.imrx earnings date · imrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
immuneering corporation revenue · imrx revenue 2025
FY 2025Net Income-$56.0M▲ +8.21% YoY
202320242025
immuneering corporation net income · imrx profit 2025
FY 2025EPS$-1.27▲ +37.75% YoY
202320242025
imrx eps · immuneering corporation earnings per share 2025
TTM:Revenue: $0.00Net Income: -$54.4MEPS: $-1.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis imrx a buy · imrx analyst rating
Strong Buy
0
Buy
7
Hold
4
Sell
0
Strong Sell
0
12-Month Price Target
$12.00Low
$3.93Current
$12.00Avg Target205.34% upside
$12.00High
imrx price target · imrx 12 month forecast

Total: 11 · Buy rate: 63.6%

The IMRX analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +205.34% upside from the current price of $3.93.

Stock Performance

Full History
1D-7.96%
1W-8.39%
1M-24.71%
3M-26.27%
YTD-40.27%
1Y+81.11%
5Y-77.66%

About Immuneering Corporation

CEOBenjamin J. Zeskind
IPO DateJul 30, 2021
Employees54
CountryUS

Immuneering Corporation is a biopharmaceutical company dedicated to developing novel therapeutic candidates in the fields of oncology (cancer) and neuroscience. Leading its clinical development effort…

what is immuneering corporation · imrx stock overview · immuneering corporation company profile · who is immuneering corporation ceo · imrx NASDAQ · immuneering corporation headquarters · immuneering corporation business segments

About Stock Overview & Key Data

Immuneering Corporation (IMRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 30, 2021. As of the latest trading session, IMRX stock price is $3.93, with a market capitalization of $142.7M. The stock has returned +81.11% over the past 12 months and -40.27% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Immuneering Corporation stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Immuneering Corporation reported revenue of — and net income of -$56.0M. For detailed data — including Immuneering Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Immuneering Corporation (IMRX) stock price is $3.93. The stock is traded on NASDAQ under the ticker symbol IMRX. The 52-week range is $1.66 – $10.08.

IMRX stock priceIMRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice